The Cannavist Issue Four | Page 19

“This is very disappointing for the tens of thousands of patients and carers having to break the law every day to obtain black market medical cannabis” - Drug Science founder Professor David Nutt but to make these products more widespread on the NHS we would need more rigorous controlled trials or observational studies that can support clinicians and give them the confidence when talking to patients about what’s right to them.” While trials have supported the development of medicines such as CBD drug epidiolex, Deacon argued that ‘you cannot pharmaceuticalise’ the plant. Instead, she said the medical community should develop an understanding of how the plant works as a whole to see its potential benefits. “It will not be put into medicines. It will never be as effective as the plant and unfortunately, until you understand how cannabis works and what it is, we are not going to move forward and I think that is extremely sad and patients will suffer.” Meanwhile, Drug Science has launched its own medical cannabis research project. The team will study the lives and experiences of 20,000 cannabis patients to document the ‘efficacy of such medicines, their safety and patient reported outcomes.’ gone from having as many as 500 seizures a month to being 11 months seizure-free. However, she was keen to point out that cannabis was not a medical cure-all, adding: “Since he’s had a prescription of cannabis oil on the NHS, he’s thrived. He’s not cured, he’s had seizures still. “This is not about saying this is a cure. This is about giving children like my son with very serious refractory epilepsy, which will kill you, the best quality of life.” A refractory condition is one that has not responded to conventional treatment. Deacon noted that ‘many hundreds of thousands’ of UK children are given unlicensed and unregulated medicines each year that are only backed by anecdotal evidence. However, cannabis is still not being readily prescribed. Instead, families have been forced to spend thousands of pounds a month on private prescriptions. Dr Chrisp said that doctors were free to prescribe cannabis but that more studies were needed: “We understand that some people do benefit